Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 917 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Turning the Life Sciences Vision into reality July 9, 2021 “Supporting research is mission critical for me and always will be”... November 29, 2021 Investing in volunteers since 2002: The tale of time July 11, 2022 Cancer Research UK releases 2022 gender and ethnicity pay gap reports March 23, 2023 Load more HOT NEWS New Immunotherapy Option Approved for Cervical Cancer, Rare Lymphoma Colonoscopy after Positive FIT Test Cuts Risk of Colorectal Cancer Death The Switch of Breast Tumours to HER2-Low Status in Recurrence Might... Identical Twins Find Strength in Shared Breast Cancer Battle After Being...
